Early On-Treatment Change in SALT as a Pragmatic Predictor of Ritlecitinib Response in Moderate-To-Severe Alopecia Areata: A Real-World Cohort Study [0.03%]
早期SALT变化作为轻中度斑块型 alopecia areata患者Ritlecitinib治疗反应的实用预测指标：一项真实世界队列研究
Giuseppe Gallo,Isotta Giunipero di Corteranzo,Pietro Quaglino et al.
Giuseppe Gallo et al.
Background: Ritlecitinib, an oral covalent Janus kinase 3 (JAK3)/TEC inhibitor, is now used for alopecia areata (AA), but pragmatic early-on-treatment markers to guide continuation decisions are needed. We evaluated wheth...
PDE4 Inhibition in Dermatologic Disease: Impacts Beyond Inflammation [0.03%]
PDE4抑制在皮肤病学中的作用：超越抗炎的功效
Keana Khodadad,Nicole E Chin,Raj Chovatiya
Keana Khodadad
Phosphodiesterase 4 (PDE4) enzymes play a central role in modulating cyclic adenosine monophosphate (cAMP) signaling and regulating diverse cellular responses. Inhibitors of PDE4 have emerged as safe and effective anti-inflammatory therapie...
Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update [0.03%]
欧洲银屑病大会专家工作组与外部专家关于炎性汗腺疾病生命质量测量的立场声明：更新版
Pavel V Chernyshov,Gregor Jemec,Andrew Finlay et al.
Pavel V Chernyshov et al.
Hidradenitis suppurativa (HS) has a profound negative impact on patients' Quality of Life (QoL). The European Academy of Dermatology and Venereology (EADV) Task Force (TF) on QoL and Patient Oriented Outcomes and TF on Acne, Rosacea and Hid...
A 52-Week Retrospective Italian Study of Flare Characteristics in Adult Atopic Dermatitis Patients Receiving JAK Inhibitors [0.03%]
一项意大利回顾性研究：JAK抑制剂治疗成人特应性皮炎患者的复发特征（第52周数据）
Claudio Brescia,Carolina D&#x;Elia,Chiara Palagiano et al.
Claudio Brescia et al.
Background: Atopic dermatitis (AD) flares occurring during treatment with Janus kinase inhibitors (JAKi) remain insufficiently characterized outside randomized clinical trials. Real-world evidence on their incidence, clin...
Angio-Invasion and Ultrasound-Guided Intralesional Amphotericin B in Eumycetoma: A Therapeutic Challenge [0.03%]
血管侵犯和超声引导下瘤体内阿莫芬康B治疗真菌足菌肿：一项挑战性治疗研究
Saurabh Singh,Prajakta Waghmare,Karthik Narasimhappa et al.
Saurabh Singh et al.
Lentigo Maligna Treated With Microscopically Controlled Surgery: A 194-Patient Retrospective Study [0.03%]
显微外科手术治疗恶性雀斑样黑色素瘤的回顾性研究(194例)
Gloria Baeza-Hernández,Ruggero Moro,Celia Requena et al.
Gloria Baeza-Hernández et al.
Background: Further studies are required to support the clinical value of paraffin-embedded microscopically controlled surgery (MCS) in lentigo maligna (LM) and lentigo maligna melanoma (LMM). ...
Longitudinal Dermoscopic and LC-OCT Monitoring of Facial Vitiligo Treated With Topical Ruxolitinib: A Pilot Prospective Study [0.03%]
鲁索利替尼局部治疗面部白癜风的纵向皮肤镜和LC-OCT监测：一项前瞻性试点研究
Ambrosio Luca,Kalaja Arlind,Picardo Mauro et al.
Ambrosio Luca et al.
Cutaneous Leiomyosarcoma of the Skin: An Updated Review of Epidemiology, Pathogenesis, and Management [0.03%]
皮肤平滑肌瘤的流行病学、发病机制和管理的最新综述更新
Tejas P Joshi,Natalie Garcia,Malak Husseinali et al.
Tejas P Joshi et al.
Primary cutaneous leiomyosarcoma (LMS) is a rare smooth muscle neoplasm encompassing a spectrum of dermal and subcutaneous tumors with distinct clinical behaviors. Dermal LMS typically presents as a small, firm nodule arising from arrector ...
Arcuate Proliferative Red Nodules on the Scalp: A Case of Syringocystadenoma Papilliferum [0.03%]
scalp的增生性红素瘤样皮损- 汗管囊腺瘤病一例
Xi Wang,Yi Dong,Ruhong Cheng
Xi Wang
Culture-Confirmed Multifocal Scrofuloderma Mimicking Hidradenitis Suppurativa in an Adolescent [0.03%]
青少年结核病多灶性瘤状皮肤结核似汗腺炎综合征
Deepak Juyal,Manish Kumar,Arti Negi et al.
Deepak Juyal et al.